Cross-reactions among carbonic anhydrases I, II, and III studied by binding tests and with monoclonal antibodies by Tashian, Richard E. et al.
Biochemical Genetics, Iiol. 20, Nos. 7/8, 1982 
Cross-Reactions Among Carbonic Anhydrases I, II, and 
llI Studied by Binding Tests and 
with Monoclonal Antibodies 
Robert P. Erickson, ~'2 Gary Kay, I David Hewet t -Emmett ,  I Richard E. 
Tashian, I and J. Latham Claflin 3 
Received 9 Oct. 1981--Final 19 Feb. 1982 
Cross-reactions among carbonic anhydrases (CAs) L II, and I l l  were studied 
using a variety o f  antisera: (1) a rabbit antiserum to bovine CA Ili,  (2) mouse 
antisera to human CA L CA II, and C.A III; and (3) f ive  monoclonal 
antibodies prepared by the hybridoma technique using splenocytes f rom a 
mouse immunized with human CAs I and H and bovine CA III. Cross- 
reactions between CAs were readily found  by binding assays using these 
antisera. Human CA L but not human CA II, inhibited the reaction o f  the 
rabbit anti-CA I I I  with its homologous antigen. Mouse antisera to CA I or 
CA H bound the homologous I or H with nearly as great efficiency as the 
autologous isozyme and sometimes weakly bound CA IlL Mouse antisera to 
CA I I I  frequently bound CA I or II. These cross-reactions were confirmed by 
the first use o f  hybridoma-prepared, monoclonal antibodies to CAs. The 
mouse monoclonal antibodies to CA isozymes varied in the amount o f  
cross-reactivity among I, II, and III: at one extreme, one monoclonal was 
highly specific for  the autologous CA III; at the other extreme, one 
monoclonal weakly reacted with some examples o f  CAs L II, and III. 
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INTRODUCTION 
The carbonic anhydrases (CA; EC 4.2.1.1) catalyze the hydration of CO2 and 
the dehydration of HCO~ and are known to occur in most prokaryotes and 
eukaryotes that have been examined. Three isozymes of carbonic anhydrase, 
CA I, CA II, and CA III, which are under the control of separate genetic loci, 
have now been characterized from vertebrate tissues. CA I (low-activity form) 
is found mainly in red cells and some other tissues (e.g., rumen epithelium, 
cecum, colonic mucosa, ciliary body), CA II (high-activity form) is found in 
red cells and almost all tissues, and CA III (low-activity, sulfonamide- 
resistant form) is found primarily in red skeletal muscle and rat liver (cf. 
Tashian, 1977; Tashian et al., 1980a,b; Kishida and Ochi, 1980; Carter et al., 
1981). Also, a particulate-bound form of CA has been reported from human 
kidney (McKinley and Whitney, 1976) and a mitochondrial CA has been 
found in guinea pig skeletal muscle and liver (Dodgson et al., 1980). These 
may represent additional isozymes of CA. 
Comparisons of the primary structures of various mammalian CA I, CA 
II, and CA III isozymes show a considerable degree of sequence homology 
(i.e., about 40% of the residues at the same positions are identical), indicating 
that these isozymes arose from a common gene by duplications well over 300 
million years ago (Tashian et al., 1980a). Antibodies prepared against a single 
isozyme will cross-react with varying intensities by immunoprecipitation with 
the same isozyme from widely separated species (cf. Tashian et al., 1968; 
Suyama et al., 1968a; Nonno et al., 1969; Fine and Laurent, 1970). However, 
immunological cross-reactions have not been detected between isozymes, not 
even between the highly homologous (about 60%) CA I and CA II sequences 
of a single mammalian species, e.g., human (cf. Micheli and Buzzi, 1964; 
Tashian et al., 1968; Suyama et al., 1968b; Fine and Laurent, 1970). Since 
only immunoprecipitation procedures have been used in these studies, it 
seemed probable that cross-reactions would be observed with the use of more 
sensitive binding assays. We report here the results of such assays in which 
cross-reactions were observed between various CA isozymes found by the use 
of a variety of antisera, including monoclonal antisera prepared by the 
hybridoma technique. 
MATERIALS AND METHODS 
Purification of Antigens 
The CA I and CA II antigens (Table I) were purified from hemolysates by 
affinity chromatography on sulfonamide (Prontosil) columns as described by 
Osborne and Tashian (1975). The CA III antigens were initially prepared 
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Table I. Carbonic Anhydrase Isozymes from Various Species Used in Cross-Reactivity Tests 
(Plus Other Control Proteins 
, i i m 
CA I CA II CA III Control 
Human Ox Ox 




Rhesus macaque Rabbit 
Sheep 
Rat 
Bovine serum albumin 
Hemoglobin 
Soybean trypsin inhibitor 
from skeletal muscle homogenates by similar affinity chromatography (Os- 
borne and Tashian, 1975) on columns equilibrated with 0.01 or 0.005 M 
Tris-SO4, pH 8.7, and eluted with a 0-0.4 M KI gradient, followed by 
purification on DEAE-32 cellulose columns equilibrated with 0.01 M Tris- 
HCI, pH 8.7, and eluted with a 0-0.2 M NaC1 gradient. If necessary, further 
purification of CA III was carried out by passage through a G-75 Sephadex 
column equilibrated with 0.05 M Tris-HC1, pH 8.0. The solutions used in the 
purification of the CA III isozymes contained 0.5 mM dithiothreitol. 
Immunizations 
Individual anti-CA sera were obtained by immunizing BC8 (C57BL/6. 
C-Igh") mice with 200 #g of either human CA l, human CA II, or bovine CA 
III at weekly intervals by the intraperitoneal route. The antigen was diluted 
with Dulbecco's CA 2+, mg 2+-free phosphate-buffered saline (PBS) so as to be 
delivered in 0.5 ml in a 50:50 homogenate with Freund's adjuvant, complete 
for the first injection and incomplete thereafter. A series of four injections was 
given, followed by a 6-week rest, and the immunization series was terminated 
with a 50-~g boost given in a similar volume. 
BALB/c mice were immunized with a mixture of human CAs I and II 
and bovine CA III in preparation for producing monoclonal antibodies by the 
hybridoma technique. The triple immunization allowed us to obtain mono- 
clonal antibodies to more than one isozyme from one fusion. To accomplish 
this, the mice were given a series of intraperitoneal injections at 2-week 
intervals of 0.2 ml of a 1:1 carbonic anhydrase (l.8-3.7 mg/ml in PBS):adju- 
vant solution (a dosage of 0.07-0.17 mg of each antigen). For the initial two 
injections, complete Freund's adjuvant was used; subsequent injections were 
done in incomplete Freund's adjuvant. Sera were obtained 2-5 days postinjec- 
tion by tail bleeding the mice. After the serum titer has reached 1 / 1000 by the 
antigen immunoadsorption test described below, the mice were given a final 
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intravenous injection of 0.1 ml of a saline solution containing 35 tzg of each 
antigen. Three days later, their spleens were removed and fused. 
Antibody to bovine CA III was prepared in a New Zealand white rabbit 
by subcutaneous injections of a mixture containing 1 mg purified CA III in 0.8 
ml 0.85% saline and 0.8 ml Freund's complete adjuvant. The same procedure 
(with Freund's incomplete adjuvant) was followed after a period of 3 weeks, 
with additional injections at weekly intervals for the following 2 weeks. The 
rabbit was bled 1 week after the last injection. 
Production of Monocional Antibodies 
The fusion technique was a modification of that described by Gefter et al. 
(1977). The specific details can be found elsewhere (Claflin et al., 1981). 
Myeloma cells (SP2/O-Ag 14) were grown in suspension in supplemental 
Dulbecco's modified Eagle (DME) + 15% fetal calf serum. Cells were fused 
in DMA + 20 mM Hepes buffer, and the fused cells were cloned in Iscove's 
modified DME (GIBCO, Grand Island, N.Y.) supplemented with 20% fetal 
calf serum, 10% NCTC 109, 1% Pen-Strep, and 3.024 g of NaHCO3 per liter 
of solution. Hybrid cells were selected in a HAT medium consisting of the 
supplemented Iscove's described above with 100 #M hypoxanthine, 10 ~M 
aminopterin, and 30 izM thymidine (Margulies et al., 1976; Littlefield, 
1964). 
Following fusion, the cells were seeded into 96-well cluster dishes 
(Costar, Cambridge, Mass.), and these dishes were examined for clones. 
When clones covered 10-20% of the surface area of the wells, supernatants 
were assayed for the presence of anti-human CA I, anti-human CA II, or 
antibovine CA III by the absorbed antigen radioimmunoassay. 
Radioimlnunoassays 
Scrum and hybridoma supcrnatants werc measured by an absorbed antigcn 
radioimmunoassay previously dcscribed (Klinman, 1972). Serum or supcrna- 
tant dilutions werc added to polyvinyl chloride microtiter platcs (Cook 
Laboratory Products Division, Dynatech Laboratories, Inc., Alexandria, Va.) 
prccoated with 0.2 ml of a 20 /~g/ml antigen solution per wcll, then with 
3,-globulin-frcc fetal calf serum (10%) as a source of blocking protcin. After 
the plates were washed, bound antibody was assayed by the addition of 
125I-labelcd anti-mouse IgG or anti-mousc Fab; wells were cut out and 
counted, using wells coated with 1% BSA in PBS as a control. 
Competitive inhibitions bctwcen antigens were performed using an 
antibody-absorbed solid-phase radioimmunoassay. A dilution of antibody 
predetermined to give maximal binding of 125I-antigcn was allowcd to adsorb 
on polyvinyl chloridc microtiter plates for 6 hr at room tempcrature. The wells 
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were washed 2× with PBS-azide (0.01% Na-azide) and allowed to soak for 
several hours in 1% ovalbumin in PBS-azide at room temperature. The 
ovatbumin was removed by aspiration and 0.2 ml of a radioactive solution 
consisting of various dilutions of inhibitors in 1% ovalbumin-PBS containing 
~251-CA (30,000 to 60,000 cpm/ml) was added. The microtiter plate was 
incubated at 37°C overnight in a humidified chamber, washed 3x with 
PBS-azide, and dried, and each well was cut out and counted. 
Radiolabeling 
Rabbit anti-mouse IgG (Gateway Immunosera, St. Louis, Mo.) or rabbit 
anti-mouse Fab (Rudikoff et al., 1972) was labeled with 125I while bound to 
mouse IgG columns (Herzenberg and Herzenberg, 1978). 
Bovine CA III was iodinated by the iodogen method (Fraker and Speck, 
1978). Briefly, 20/zg of bovine CA II1 was incubated with 200 #Ci Na ~25I for 
1 rain at room temperature in a chloroglyeoluril-coated tube in 100 #1 of 0.7 
MNaC1, 0.2 M potassium phosphate, pH 7.0. The 125I-CA was separated from 
Na ~25I on Sephadex G-25 by collection 0.5-ml samples in tubes which already 
contained a drop of 1% ovalbumin. The two tubes containing the first peak 
were pooled with rinses of 1% ovalbumin in PBS and then dialyzed for further 
removal of free NA ~25I. The final specific activity was 0.3 #CI/#g. 
RESULTS 
The binding of 125I-bovine CA II1 by rabbit anti-bovine CA III serum was 
strongly inhibited by cold bovine CA III and weakly inhibited by cold human 
CA I (Fig. 1). The inhibition by the cross-reacting CA I was 3 orders of 
magnitude weaker than the autologous reaction and it did not go to comple- 
tion. Human CA II did not significantly inhibit the binding of bovine CA IlI 
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Fig. 1. Inhibition of binding of 30 ng 1251-bovine CA III to immunoadsorbed rabbit 
anti-bovine CA III by (O) bovine CA III, (e) human CA I, and (A)  human CA II. 
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Cross-reactions of anti-CA antibodies were studied in more detail using 
direct immunoadsorption of mouse anti-CA antibodies. A number of sera 
were tested and most showed cross-reactions between isozymes. Several 
representative patterns are shown in Fig. 2. Antisera to CA I or CA II 
frequently reacted nearly as well to the other red blood-cell isozyme as to the 
autologous antigen, e.g., anti-I in Fig. 2A and anti-II in Fig. 2C. The anti-CA 
I or II usually also reacted quite well with CA III (even from a different 
species) (Figs. 2A and C). Some antisera showed much stronger binding 
reactions with autologous antigen than with other CA isozymes, e.g., another 
anti-I in Fig. 2D. Antisera to Ca III were usually weaker than antisera to CA I 
or II but they frequently showed good cross-reactions with CA I or II, e.g., 
Fig. 2B demonstrates a cross-reaction of anti-IlI with CA II; similar reactions 
with CA I were sometimes found (not shown). 
We sought to understand further the nature of the cross-reactions 
between the CA isozymes by using monoclonal antibodies prepared by the 
hybridoma technique. The fusion of the mice spleen cells with the SP2 
myeloma cells resulted in 644 microtiter wells, of which 32 yielded clones, an 
efficiency rate of 5%. Of these 32 clones, 8 showed anti-carbonic anhydrase 
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Fig. 2. Cross-reactions in the antigen immunoad- 
sorption test of individual mouse antisera to 
human CA I (A, D), human CA III (B), and 
human CA II (C) with human CA I (---O---), 
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activity (25% of the clones and 1.25% of the total fusion). The reactivity of the 
hybridoma supernatants was determined by a counting ratio of the reaction of 
the antibody with the carbonic anhydrase to the antibody with bovine serum 
albumin: 
counting ratio (CR) = 
cpm 125I-ab-ab-CA 
cpm ~zSI-ab-ab-BSA" 
All the monoclonal supernatants were tested for immunoprecipitation with all 
three antigens by double diffusion and all were negative as is expected for the 
reaction of a monoclonal antibody with a monomeric antigen. Table II 
indicates the cross-reactivity patterns of supernatants from five of the eight 
positive clones (three lost secretory activity too early for testing). The 
especially significant results in Table II are italicized. Several interesting 
patterns are readily seen. Clone 2G-4 reacted well with bovine CA 1II, one of 
the antigens used to immunize the triply immunized mice, and not at all with 
any other CA isozymes, including other CA III's. Clone 12C-8 probably 
originated from the fusion of a spleen cell which had responded to human CA 
II since the strongest reactions occurred with CA II from three species. A 
nearly equivalent reaction occurred to human CA I and significant reactions 
occurred with chicken and rabbit CA III. Clone 2B-7 was presumably also 
directed against human CA II but reacted more strongly with rhesus CA II 
than with the autologous antigen. This monoclonal antibody also reacted with 
some CA llI's. Similarly, clone 10E-3 reacted most strongly with human and 
rat CA II and moderately with several CA III's. Clone 2D-2 reacted weakly 
with almost all CA isozymes--the concentration of antibody in this superna- 
tant may have been lower than that with the other clones. 
DISCUSSION 
The population of antibody molecules resulting from immunization with 
various poly-oe-amino acids clearly includes many with combining sites 
interacting with five or six amino acid residues (cf. Arnon et al., 1965; Kabat, 
1966; Twining et  al., 1980, and references therein). Thus, the 60% amino acid 
sequence homology between human CA I and human CA II and their very 
similar topography by X-ray crystallography (Kannan, 1980) would lead to a 
prediction of some immunological cross-reactivity. For instance, bovine and 
guinea pig a-lactalbumins, with about 60% homology in amino acid sequence, 
show a definite cross-reaction (Erickson and Rosenberg, 1973). Such cross- 
reactions have probably not been found previously because binding studies of 
antibodies to carbonic anhydrases have not been previously performed. 
We found that most polyva!ent rabbit and mouse antisera showed 
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cross-reactions between CA I and CA II while weaker cross-reactions between 
CA III and CA I and/or CA li were found. Some of the differences in 
reactivity suggest that species-specific determinants are also being detected. 
For instance, anti-human CA I and anti-human CA II react better with 
human CA I or II than with bovine CA III (Figs. 2A, C, and D). Similarly, 
anti-bovine CA III reacts better with the homologous antigen than with the 
human CA III isozyme (Table II), 
Monoclonal antisera raised by the hybridoma technique appeared to 
detect single haptens (as expected) since the cross-reactions were more 
individualized: one clone showed cross-reactions between CA II and CA III. 
Perhaps greater cross-reactions with CA I would have been detected if as 
many different species examples of CA I had been tested. 
Of interest is the observation that several of the monoclonal anticarbonic 
anhydrase antibodies reacted more strongly with homologous CAs from 
species other than the immunizing species (Table II), e.g., 2B-7 reacted 
fourfold better with rhesus CA II than with the human CA II immunogen. 
Such idiosyncratic reactions of monoclonal antibodies are also being found in 
other systems. The recent report of a cross-reaction of anti-Thy 1.1 mono- 
clonal antibody with vimentin was interpreted in terms of a possible shared 
carbohydrate between vimentin and Thy-1 (Dulbecco et al., ! 981). An earlier 
report (Pillemer and Weismann, 1981) of cross-reaction of an anti-Thy i 
monoclonal with an anti-phosphorylcholine idiotypic specificity of mouse 
antibodies was interpreted in terms of possible evolutionary homology of the 
Thy 1 molecule with antibodies. (Since it is a very low percentage of 
homology, this degree of cross-reaction would not be expected, however.) 
An alternative explanation of these cross-reactions may be the phenome- 
non of "half-site reactivity." In other words, monoclonal-secreting hybrido- 
mas are selected with such sensitive immunoassays that low-affinity antibod- 
ies are chosen. As Landsteiner demonstrated some years ago, in studies of 
artificial haptens, low-avidity antisera show quite wide cross-reactions with 
heterologous antigens (Landsteiner, 1946). Since an antibody combining site 
has a fairly fixed size, antibody production may be elicited to haptens which 
only partially correspond to the combining site. The potential for antigen 
binding by antibody when only a portion of the combining site is involved is 
suggested by fractionation studies of antihapten antibodies which detect some 
antibodies reacting with subportions of the hapten while others seem to be 
specific for the larger, total hapten (Pressman and Grossberg, 1973). This 
lack of specificity might especially be expected for IgM monoclonals since 
their maximal association constants, at least in the case of antilactosyl 
antibodies, are 50-fold lower than those for IgG monoclonals (Mandal and 
Karush, 1981). 
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